Pediatricians are urged to follow 2024 guidelines amid ACIP upheaval, vaccine hesitancy, and access issues as children head ...

Elizabeth Reichert, PhD, shared practical tips for pediatricians to help families monitor teen media use and recognize early signs of anxiety.

An expert discusses the formal diagnostic criteria and diverse clinical presentations of atopic dermatitis, emphasizing patient-centered assessment, challenges in distinguishing it from similar ...

The American Academy of Pediatrics (AAP), an organization made up of more than 67,000 pediatricians, pediatric medical subspecialists, and surgical specialists, has released its influenza vaccine ...

On July 28, 2025, the FDA approved PTC Therapeutics' sepiapterin (Sephience) to treat adult and pediatric patients with phenylketonuria (PKU), including all age groups and the full spectrum of disease ...

On July 30, 2025, AbbVie announced positive and topline data from the phase 3 UP-AA clinical program (NCT06012240), in which upadacitinib (Rinvoq) (15 mg and 30 mg) demonstrated that 44.6% and 54.3% ...

Suzanne Hollander, MS, RD, LDN and Timothy Tramontana, MD offer thoughts on the newly FDA-approved sepiapterin for PKU. On July 28, 2025, the FDA approved PTC Therapeutics' sepiapterin (Sephience) to ...

The FDA has approved avatrombopag and new sprinkle formulation for children ≥1 year with chronic ITP, offering an oral, food-flexible treatment option.

As children head back to school, pediatric pulmonologist Richard Wong, DO, of Phoenix Children’s, warns that asthma management becomes more complex outside the home. With increased exposure to ...

J&J is seeking the first approval for the investigational targeted oral peptide to treat patients 12 years or older with moderate to severe plaque psoriasis.

Marian F. Earls, MD, MTS, FAAP, is board certified in both general pediatrics and developmental and behavioral pediatrics. Her career has focused on Medicaid and Early and Periodic Screening, ...